After graduating with a Bachelor's degree in Pharmacy from China Pharmaceutical University in 2013, I entered the School of Biomedical Sciences (SBS) at The Chinese University of Hong Kong (CUHK) to pursue my Ph.D., under the supervision of Prof. Yao Xiaoqiang, conducting research on ion channels and cardiovascular diseases. Later, I worked as a research assistant in Prof. Zhao Hui’s lab, focusing on developmental biology.

During my four years at SBS, I grew from a novice, unfamiliar with research, into an independent researcher capable of conducting experiments and publishing SCI papers, ultimately earning my Ph.D. This growth was made possible through the patient guidance and strong support of professors such as Prof. Yao Xiaoqiang, Prof. Zhao Hui, and Prof. Huang Yu, along with the help of my classmates who shared the similar struggles and achievements in the Lo Kwee-Seong Integrated Biomedical Sciences Building. I also received support from CUHK staff who ensured my safety during late nights after experiments. My time in Hong Kong and at CUHK is filled with fond memories of a rich and systematic professional training in basic medicine and life sciences. After graduation, I successfully joined Kunming Medical University as a faculty member, where I continue to pass on the knowledge and cultural values I gained at CUHK to my students.

In 2018, I joined School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming. Since 2020, I have served as a Master's supervisor and was promoted to Associate Professor in 2021. In 2022, I became a Ph.D. supervisor. At Kunming Medical University, my research primarily focuses on cardiovascular and cerebrovascular diseases and the pharmacology of natural products. I am dedicated to exploring the therapeutic potential of natural products in cardiovascular disease and the mechanisms underlying infectious cardiovascular diseases.

My research has been recognized by both society and academia. In 2019, I was honoured with the "Yunnan Revitalization Talent Support Program" Youth Scholars, and in 2022, my team received the "Youth Civilization Award" from Kunming Medical University. That same year, I was awarded the Yunnan Provincial Science and Technology Department–Kunming Medical University for Distinguished Young Scholars. I also won the second prize in the Yunnan Provincial Health Science and Technology Achievement Award in 2022 and the third prize in 2023.

My team, the "Kunming Medical University Scientific Innovation Team for Infectious Cardiovascular Diseases and Drug Development," focuses on research and translation of cardiovascular damage caused by viral infections and strives to apply our research to clinical settings. So far, I have published 49 papers, 44 of which are SCI-indexed. As the first or corresponding author, I have published 26 SCI papers in journals such as PNAS, Acta Pharmacol Sin, Natl Sci Rev, and JAHA. I have also led multiple research projects, including three National Natural Science Foundation grants, and hold five national patents.

It has been six years since I left CUHK. I have grown from a student into a Ph.D. supervisor, leading my own team in cardiovascular pharmacology research. There is an old saying: "One does not understand the cost of living until they are responsible for it." In these years of teaching, leading my team, I have deeply appreciated the passion of each professor in SBS for research and their dedication to students. I am immensely grateful to my alma mater, SBS, and to Prof. Yao Xiaoqiang for nurturing me. As the Year of the Snake approaches in 2025, I wish SBS continued success in cultivating world-class academic talents. I wish all teachers and students good health and all the best in the coming year.

Prof. Zheng Changbo (2nd from right) and Prof. Yao Xiaoqiang (2nd from left)

2013年我在中國藥科大學藥學專業本科畢業後，進入香港中文大學生物醫學學院(SBS)攻讀博士，師從姚曉強教授進行離子通道與心血管疾病的研究。隨後以研究助理的身份在趙暉教授實驗室進行發育的相關研究。

在香港中文大學生物醫學學院學習的四年裡，我從一個剛入學時對科研一無所知的小夥，成長為自己能夠獨立開展實驗並發表SCI論文獲得博士學位的合格學生，離不開姚曉強教授、趙暉教授、黃聿教授等SBS的許多教授對我的耐心指導和大力支持，更離不開那四年同在羅桂祥綜合生物醫學大樓內一同奮鬥、給我生活和科研上提供幫助的同學;甚至還有凌晨做完實驗回宿舍的路上遇到關心我安全，執意護送我回宿舍的中大普通職工。讓我在香港、在CUHK的四年間充滿著美好的回憶，充實、系統地接受基礎醫學、生命科學領域的專業訓練。畢業後，我順利地入職昆明醫科大學藥學院，成為一名高校教師，繼續將在SBS所學專業知識、所接受的中大文化與精神傳承給我的學生。

2018年，我進入昆明醫科大學藥學院暨天然藥物藥理重點實驗室，擔任講師。自2020年起，我被授予碩士研究生導師資格，2021年晉升為副教授，2022年成為博士研究生導師。在昆明醫科大學，我主要從事心腦血管系統疾病機制及天然藥物藥理研究，致力於通過天然產物防治心血管疾病、探索感染性心血管疾病的前沿機制，並研發天然產物靶點。我的科研工作得到了社會和學術界的認可，2019年獲「雲南省興滇人才青年人才」稱號，2022年帶領團隊獲得昆明醫科大學「青年文明號」榮譽稱號。同年，我還獲得了雲南省科技廳-昆醫聯合專項傑青培育人才專項資助，並在2022年、2023年分別獲得雲南省衛生科技成果二等獎（排名第二）和三等獎（排名第八）。我的團隊「昆明醫科大學感染性心血管疾病與藥物研發科技創新團隊」致力於病毒感染導致的心血管損傷的研究與轉化，努力推動科研成果的臨床應用。目前，我在國內外學術期刊上發表了49篇論文，其中44篇為SCI收錄，作為第一作者或通訊作者在PNAS、Acta Pharmacol Sin、Natl Sci Rev、JAHA等期刊發表的SCI論文有26篇。此外，我主持了多項科研項目，包括三項國家自然科學基金，並獲得五項國家專利。

離開香港中文大學轉眼已經六年。我自己也從一名學生成長為一名博士生導師，帶領自己的團隊開展心血管藥理方面的研究。有句老話叫「不當家不知柴米貴」，在大學任教的這些年自己帶領團隊後才能深刻感受到SBS每一位教授對科研熱情和對學生的傾情付出，感謝母校、感謝SBS，感謝姚曉強教授對我的栽培。2025年蛇年春節將至，在此我祝福SBS能夠持續培養國際一流學術人才，蛇年大吉，各位師生身體健康，萬事如意！

鄭昌博教授（右二）與姚曉強教授（左二）

2013年我在中国药科大学药学专业本科毕业后，进入香港中文大学生物医学学院(SBS)攻读博士，师从姚晓强教授进行离子通道与心血管疾病的研究。随后以研究助理的身份在赵晖教授实验室进行发育的相关研究。

在香港中文大学生物医学学院学习的四年里，我从一个刚入学时对科研一无所知的小伙，成长为自己能够独立开展实验并发表SCI论文获得博士学位的合格学生，离不开姚晓强教授、赵晖教授、黄聿教授等SBS的许多教授对我的耐心指导和大力支持，更离不开那四年同在罗桂祥综合生物医学大楼内一同奋斗、给我生活和科研上提供帮助的同学;甚至还有凌晨做完实验回宿舍的路上遇到关心我安全，执意护送我回宿舍的中大普通职工。让我在香港、在CUHK的四年间充满着美好的回忆，充实、系统地接受基础医学、生命科学领域的专业训练。毕业后，我顺利地入职昆明医科大学药学院，成为一名高校教师，继续将在SBS所学专业知识、所接受的中大文化与精神传承给我的学生。

2018年，我进入昆明医科大学药学院暨天然药物药理重点实验室，担任讲师。自2020年起，我被授予硕士研究生导师资格，2021年晋升为副教授，2022年成为博士研究生导师。在昆明医科大学，我主要从事心脑血管系统疾病机制及天然药物药理研究，致力于通过天然产物防治心血管疾病、探索感染性心血管疾病的前沿机制，并研发天然产物靶点。我的科研工作得到了社会和学术界的认可，2019年获「云南省兴滇人才青年人才」称号，2022年带领团队获得昆明医科大学「青年文明号」荣誉称号。同年，我还获得了云南省科技厅-昆医联合专项杰青培育人才专项资助，并在2022年、2023年分别获得云南省卫生科技成果二等奖（排名第二）和三等奖（排名第八）。我的团队「昆明医科大学感染性心血管疾病与药物研发科技创新团队」致力于病毒感染导致的心血管损伤的研究与转化，努力推动科研成果的临床应用。目前，我在国内外学术期刊上发表了49篇论文，其中44篇为SCI收录，作为第一作者或通讯作者在PNAS、Acta Pharmacol Sin、Natl Sci Rev、JAHA等期刊发表的SCI论文有26篇。此外，我主持了多项科研项目，包括三项国家自然科学基金，并获得五项国家专利。

离开香港中文大学转眼已经六年。我自己也从一名学生成长为一名博士生导师，带领自己的团队开展心血管药理方面的研究。有句老话叫「不当家不知柴米贵」，在大学任教的这些年自己带领团队后才能深刻感受到SBS每一位教授对科研热情和对学生的倾情付出，感谢母校、感谢SBS，感谢姚晓强教授对我的栽培。 2025年蛇年春节将至，在此我祝福SBS能够持续培养国际一流学术人才，蛇年大吉，各位师生身体健康，万事如意！

郑昌博教授（右二）与姚晓强教授（左二）